The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: First results of the Burden of Communicable Diseases in Europe Study

Epidemiology and Infection

Volumn 142, Issue 10, 2014, Pages 2024-2035

  Plass, D ^a   Mangen, M J J ^b   Kraemer, A ^a   Pinheiro, P ^a   Gilsdorf, A ^c   Krause, G ^c,d   Gibbons, C L ^e   Van Lier, A ^f   McDonald, S A ^f   Brooke, R J ^b   Kramarz, P ^g   Cassini, A ^g   Kretzschmar, M E E ^b,f  

^a BIELEFELD UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ROBERT KOCH INSTITUTE   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^g EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Disability adjusted life years; hepatitis B; influenza; measles (rubeola); Salmonella

Indexed keywords

ADL DISABILITY; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BACTERIAL TRANSMISSION; DISEASE COURSE; DISEASE SURVEILLANCE; FEMALE; GERMANY; HEALTH STATUS; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; INFANT; INFLUENZA; INFLUENZA VIRUS; LIFE EXPECTANCY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VIRUS; NEWBORN; NONHUMAN; PATHOGEN LOAD; RISK ASSESSMENT; SALMONELLA; SALMONELLOSIS; SUBACUTE SCLEROSING PANENCEPHALITIS; TREND STUDY; VIRUS TRANSMISSION; ACUTE DISSEMINATED ENCEPHALOMYELITIS; AGE DISTRIBUTION; COMPENSATED LIVER CIRRHOSIS; DECOMPENSATED LIVER CIRRHOSIS; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; DISEASE BURDEN; ENCEPHALITIS; FULMINANT HEPATIC FAILURE; HEALTH CARE CONCEPTS; HEARING IMPAIRMENT; IRRITABLE COLON; LIVER CELL CARCINOMA; REACTIVE ARTHRITIS; SEPSIS; SEX RATIO; YEARS LIVED WITH DISABILITY; YEARS OF LIFE LOST DUE TO PREMATURE DEATH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HEPATITIS B; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; INFANT; INFLUENZA, HUMAN; LIVER FAILURE, ACUTE; LIVER NEOPLASMS; MALE; MEASLES; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; RESPIRATORY DISTRESS SYNDROME, ADULT; SALMONELLA INFECTIONS; YOUNG ADULT;

EID: 84906264480     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813003312     Document Type: Article

References (33)

1. Paoli F. Health at a glance: Europe 2010. European Journal of Public Health 2011; 21: 266-267.
2. Viergever RF, et al. A checklist for health research priority setting: nine common themes of good practice. Health Research Policy and Systems 2010; 8: 36.
3. Sibbald SL, et al. Evaluating priority setting success in healthcare: a pilot study. BMC Health Services Research 2010; 10: 131.
4. Berra S, et al. Setting priorities in clinical and health services research: properties of an adapted and updated method. International Journal of Technology Assessment in Health Care 2010; 26: 217-224.
5. Sibbald SL, et al. Priority setting: what constitutes success? A conceptual framework for successful priority setting. BMC Health Services Research 2009; 9: 43.
6. Munoz N, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine 2003; 348: 518-527.
7. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Amercan Journal of Gastroenterology 2007; 102: 1789-1798.
8. zur Hausen H. The search for infectious causes of human cancers: where and why. Virology 2009; 392: 1-10.
9. Parkin DM. The global health burden of infectionassociated cancers in the year 2002. International Journal of Cancer 2006; 118: 3030-3044.
10. Balabanova Y, et al. Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS One 2011; 6: e25691.
11. Murray CJL, Lopez AD. The Global Burden of Disease-A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge: Harvard School of Public Health on behalf of the World Health Organization and the World Bank, 1996.
12. Murray CJL. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bulletin of the World Health Organization 1994; 72: 429-445.
13. Zou S. Applying DALYs to the burden of infectious diseases. Bulletin of the World Health Organization 2001; 79: 267-268.
14. Kretzschmar M, et al. New methodology for estimating the burden of infectious diseases in Europe. PLoS Medicine 2012; 9: e1001205.
15. European Centre for Disease Prevention and Control. Methodology protocol for estimating burden of communicable diseases. Stockholm: European Centre for Disease Prevention and Control, 2010.
16. Mangen M, et al. The pathogen-and incidence-based DALY approach-an appropriated methodology for estimating the burden of infectious diseases. PLoS ONE. Published online: 20 November 2013. doi:10.1371/journal.pone.0079740.
17. Havelaar AH, et al. Health burden in the Netherlands due to infection with thermophilic Campylobacter spp. Epidemiology and Infection 2000; 125: 505-522.
18. van Lier EA, Havelaar AH, Nanda A. The burden of infectious diseases in Europe: a pilot study. Eurosurveillance 2007; 12(12
19. WHO. The global burden of disease: 2004 update. Geneva: World Health Organization, 2008, pp. 146.
20. Michaud C, et al. The burden of disease and injury in the United States 1996. Population Health Metrics 2006; 4:11.
21. WHO. Country specific life expectancy, World Health Organization, 2008.
22. Robert Koch Institut. SurvStat (http://www3rkide/SurvStat), 2011. Accessed 30 September 2011.
23. Gibbons C, et al. Estimating the extent of underreporting and under-ascertainment of infectious diseases BMC Public Health (in press
24. WHO. Department of Vaccines and Biologicals. Introduction of hepatitis B vaccine into childhood immunization services: management guidelines, including information for health workers and parents. Geneva: World Health Organization, 2001, pp.48.
25. Alter MJ, et al. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. American Journal of Epidemiology 1987; 125: 133-139.
26. Ramsay M, et al. Control of hepatitis B in the United Kingdom. Vaccine 1998; 16 (Suppl. 1): S52-S55.
27. Dijkstra F, et al. Long time trends in influenzalike illness and associated determinants in The Netherlands. Epidemiology and Infection 2009; 137: 473-479.
28. Wichmann O, et al. Large measles outbreak at a German public school, 2006. Pediatric Infectious Disease Journal 2007; 26: 782-786.
29. Stein CE, et al. The global burden of measles in the year 2000-A model that uses country-specific indicators. Journal of Infectious Diseases 2003; 187 (Suppl. 1): S8-14.
30. Havelaar AH, et al. Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009. Epidemiology and Infection 2013; 141: 293-302.
31. McDonald S, et al. The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. BMC Public Health 2012; 12: 1-11.
32. Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. American Journal of Epidemiology 2002; 155: 866-874.
33. Haagsma J, et al. Community incidence of pathogenspecific gastroenteritis: reconstructing the surveillance pyramid for seven pathogens in seven European Union member states. Epidemiology and Infection 2013; 141: 1625-1639.